Annual Drug Patent Expirations for EQUETRO Equetro is a drug marketed by Validus Pharms and is included in one NDA. It is available from one supplier. There is one patent…
Source
New patent expiration for Validus Pharms drug EQUETRO Read Post »
Annual Drug Patent Expirations for ULESFIA Ulesfia is a drug marketed by Shionogi Inc and is included in one NDA. There is one patent protecting this drug and one Paragraph…
Source
New patent expiration for Shionogi Inc drug ULESFIA Read Post »
ADASUVE (loxapine) Alexza pharms Patent: 9,370,629 Expiration: May 20, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
Source
Drug Patent Expirations for the Week of May 19, 2024 Read Post »
This chart shows the pharmaceutical companies with the most suppository dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suppository dosed drugs…
Source
Which pharmaceutical companies have the most suppository dosed drugs? Read Post »
Annual Drug Patent Expirations for TADLIQ Tadliq is a drug marketed by Cmp Dev Llc and is included in one NDA. It is available from one supplier. There are two…
Source
Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are six…
Source
Annual Drug Patent Expirations for NEXLETOL Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are four…
Source
Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one NDA. It is available from one supplier. There are twelve…
Source
New patent expiration for Alnylam Pharms drug GIVLAARI Read Post »
Annual Drug Patent Expirations for TYMLOS Tymlos is a drug marketed by Radius and is included in one NDA. It is available from one supplier. There are eight patents protecting…
Source
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are thirteen patents protecting…
Source